Gregory W. Albers

Title
Director of Stanford Stroke Center

Department
Neurology and Neurological Sciences

Research Interests
New pharmacological approaches for stroke treatment and prevention; imaging methods for early identification of ischemic brain tissue.

Email
albers@leland.stanford.edu

Phone
723-4448

Fax

Address
701 Welch Road #325
Mail Code: 117

Faculty Research Description
Clinical research focused on acute treatment and prevention of cerebrovascular disease. Ongoing clincial studies include NMD antagonists and tissue plasminogen activator for treatment of acute stroke. Stroke prevention trials include new antiplatelet and anticoagulant strategies for patients at high risk of stroke. Other interests include diffusion weighted MRI, transesophogeal echocardiography and brain ischemia during cardiac bypass surgery.

Albers GW, Comess KA, DeRook FA, Bracci P, Atwood JE, Bolger A, Hotson J. Transesophageal echocardiographic findings instroke subtypes. Stroke. 25:23-28, 1994.

Feinberg WM, Albers GW, Barnett HJ et.al. Guidelines for the management of transient ischemic attacks: AHA medical/scientific statement. Stroke. 25:1320-1335, 1994.

Albers GW, Atkinson R, Kelley R, Rosenbaum D. Safety tolerability and pharmacokinetics of the N-methyl-D aspartate antagonist dextrorphan in patients with an acute stroke. Stroke. 26:254-258, 1995.

Albers GW. Role of ticlopidine for prevention of stroke. Stroke. 23:912-916, 1992.

Albers GW. Laboratory monitoring of oral anticoagulant therapy: are we being misled? Neurol. 43:468-470, 1993. Expedited publication.

Areas of Study
SBRC